MedPath

HypnoTreat: Reduction of oxidative stress, increased inflammatory processes and improvement of mitochondrial function through hypnosis

Not Applicable
Conditions
chronic stress
Registration Number
DRKS00027356
Lead Sponsor
Institut für Psychologie und Pädagogik, Universität Ulm
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
47
Inclusion Criteria

Age at least 18 years; sufficient knowledge of German; good hypnotizability of the subjects (score HGSHS:A = 6; BER: medium to high scores, i.e. 24-48); ability of the subject to give consent; signed consent form.
Healthy or health stable subjects; High subjective stress level.

Exclusion Criteria

Excludes individuals with acute and past neuropsychiatric disorders or diseases, including Parkinson's disease, Alzheimer's disease, schizophrenia, and substance abuse. Also, individuals with known anemia, immune disorders, autoimmune diseases, acute cancer and diabetes mellitus, and known chronic viral infections such as HIV and hepatitis. Also excluded are individuals who are taking medications with known influence on the immune system, for example immunosuppressants, cytostatics or comparable relevant substance classes, or who have been vaccinated in the past 7 days prior to study inclusion. The intake of iron or vitamin E supplements in a dose of more than 800 IU per day is also an exclusion criterion. Further exclusion criteria are inadequate German language skills and acute mental illnesses

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcomes will be measured using participants' whole blood and immune cells at pre- and post-intervention ATP-turnover-related respiration, uncoupled respiration, and routine respiration will be measured on immune cells using high-resolution respirometry. Mitochondrial density of immune cells will be determined spectrophotometrically.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes will include differential blood work and inflammatory parameters (CRP, IL-1beta, IL-6,TNF-alpha) and psychological standardized questionnaires (anxiety, affect, stress).
© Copyright 2025. All Rights Reserved by MedPath